Grace Therapeutics, Inc. (GRCE)

Financing Cash Flow

$0.00

Quarterly · Period ending: · USD

GRCE logo

GRCE Financing Cash Flow

Latest reported$0.00
GRCE Quarterly Cash from Financing ($27.52 → $0.00)
High-resolution chart · PNG

GRCE financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
0
-769
4,040,769
-769
-327,000
14,032,000
0
0
0
0
0
7,359,000
0
0
0
109,000
195,000
0
0
0
0
43,564,121
25,211,995
4,569,295
2,217,476
-974,565
7,117,000
6,596,000
34,000
-840,469
36,000,675
-97,522
7,935,675
20,880
9,434,592
-806
-323,706
-744
-2,291
-9,967
61
-828
-304
-774
-4,445
-786
-1,640
45,927
21,549,973
505,340
364,374
18,860
179,126
4,024
25,885
12,050
2,288,000
7,619,426
36,089
-394
179,065
4,216,730
-160
520
75,954
415
1,004
28
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.